Personalis, Inc. (PSNL) stock

Services-Medical Laboratories

Personalis, Inc. (PSNL) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.

What’s happening with Personalis, Inc.

Personalis, Inc. stock — financials & valuation

AllSight quality score: 27/100 — a percentile rank of Personalis, Inc.’s fundamentals against Services peers.

Is Personalis, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Personalis, Inc. (PSNL) analyst ratings & price target

Consensus: Buy from 12 analysts (Buy 9 · Hold 3).

Average price target: $14.95 (−8.2% vs $16.28); range $9–$17.

Wall Street analyst consensus, shown as context — not an AllSight view.

Personalis, Inc. (PSNL) insider trading

Open-market buys: 14 · Open-market sells: 73 · Net: +$19.4M

Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.

Personalis, Inc. news, decoded

Personalis, Inc. (PSNL) Stock — News, Financials & Insider Trading
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
AllSight

Sign in to AllSight

Save tickers, get email alerts and upgrade — it starts with your email.

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.